Skin & Cellular Research

GHK-Cu (50mg)

Research GHK-Cu vial, dispatched from Australian stock. In Stock

Other sizes

Copper-binding tripeptide (glycyl-L-histidyl-L-lysine:Cu²⁺)

GHK-Cu is a naturally occurring tripeptide that binds copper with high affinity. It was first isolated from human plasma in 1973, where its concentration falls from roughly 200 ng/mL in young adults to about 80 ng/mL by age 60. Research interest spans wound repair, collagen synthesis, hair follicle biology and gene-expression modulation in aged tissue. The same molecule appears at low concentration in cosmetic serums; the research vial is the pure copper complex.

The 50mg vial is the entry format for GHK-Cu: enough for assay development and first-run comparisons without committing to a larger quantity. Larger vials cost less per milligram ($1.50/mg at 100mg versus $2.00/mg here).

The full research summary, mechanism and legal status are on the GHK-Cu page.

Key research areas

• Collagen and elastin synthesis — Fibroblast stimulation and lysyl oxidase activity
• Wound healing — Closure rate and remodelling in animal and human wounds
• Gene expression — Broad transcriptional effects in aged and cancer cell lines
• Hair follicle biology — Follicle size and growth-phase markers
• Antioxidant defence — SOD activation and iron release inhibition

Also known as: Copper peptide, GHK copper, GHKCu, Copper tripeptide-1, ghku, chk cu, ghcku, copper tripeptide-1

Certificate of analysis. Every batch carries a certificate from an independent laboratory. Request the certificate for your batch with your order number and we send it.

For in-vitro research and laboratory use only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws.